EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Examining the Outcome of Osteosarcoma: 10-Year Experience in a Referral Center South of Iran

Saeed Solooki, Yaser Mansoori, Mohammad Hadi Gerami, Seyed Arman Moein, Jamshid Jamali

Reports of Radiotherapy and Oncology · 2023

DOI: 10.5812/rro-134324 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Reports of Radiotherapy and Oncology, 2023. Verfasst von Saeed Solooki und 4 weiteren Autor:innen. Die Arbeit nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Osteosarcoma is a primary and malignant bone tumor. Currently, using neoadjuvant chemotherapy, surgery, and appropriate adjuvant chemotherapy, long-term survival of more than 70% can be expected for patients affected by this disease. Therefore, the combination of different treatment methods increases the chances of saving the limb.

Objectives

In this study we intend to share our 10-year experience in the management of osteosarcoma in Shiraz as the referral center of south of Iran.

Methods

In this retrospective cohort study, 56 patients with osteosarcoma who were referred to Chamran and Namazi hospitals between 2008 and 2017, were included. Age, sex, site of involvement, presence of metastasis, treatment procedure, treatment outcomes, and survival time were studied. Kaplan-Meier method was used for survival analysis. Log rank test was applied for comparison of survival time according to sex. SPSS software version 25 (SPSS Inc., Chicago, US) was used for statistical analysis. Significance level considered P-value less than 0.05.

Results

Among these patients, 33 were men 23 were women, with an average of 10 to 68 years old. In our study, distal femur was the most common site for osteosarcoma. Moreover, 44.6% of the patients undergone amputation. The best treatment results are in patients who received neoadjuvant chemotherapy followed by surgery. Finally, 77% of patients had a 2-year survival rate, and 57% had a 5-year survival rate.

Conclusions

There has been a significant advancement in the treatment of osteosarcoma. A multifaceted approach to this disease, including surgery and chemotherapy has increased the possibility of better prognosis for this disease. Early diagnosis and appropriate treatment in the form of neoadjuvant chemotherapy, surgery with appropriate margin removal, and adjuvant chemotherapy are suggested for this tumor.

Zitieren

APA

Solooki, S., Mansoori, Y., Gerami, M. H., Moein, S. A., & Jamali, J. (2023). Examining the Outcome of Osteosarcoma: 10-Year Experience in a Referral Center South of Iran. Reports of Radiotherapy and Oncology. https://doi.org/10.5812/rro-134324

Vancouver

Solooki S, Mansoori Y, Gerami MH, Moein SA, Jamali J. Examining the Outcome of Osteosarcoma: 10-Year Experience in a Referral Center South of Iran. Reports of Radiotherapy and Oncology. 2023. doi:10.5812/rro-134324

BibTeX
@article{Solooki2023,
  author = {Solooki, Saeed and Mansoori, Yaser and Gerami, Mohammad Hadi and Moein, Seyed Arman and Jamali, Jamshid},
  title = {Examining the Outcome of Osteosarcoma: 10-Year Experience in a Referral Center South of Iran},
  journal = {Reports of Radiotherapy and Oncology},
  year = {2023},
  doi = {10.5812/rro-134324}
}
Kostenlos starten →